Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report

INTRODUCTION: Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system. To date, optimal therapeutic approaches for neuromyelitis optica have yet to be defined. Natalizumab is highly effective in relapsing-remitting multiple sclerosis and might be considered as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, De-Hyung, Laemmer, Alexandra B, Waschbisch, Anne, Struffert, Tobias, Maihöfner, Christian, Schwab, Stefan, Linker, Ralf Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046517/
https://www.ncbi.nlm.nih.gov/pubmed/24886528
http://dx.doi.org/10.1186/1752-1947-8-155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046517/
https://www.ncbi.nlm.nih.gov/pubmed/24886528
http://dx.doi.org/10.1186/1752-1947-8-155

Ejemplares similares